uBriGene Biosciences
uBriGene Biosciences Inc. is a global leader in cell and gene therapy, functioning as a Contract Development and Manufacturing Organization (CDMO). Based in Maryland, USA, the company has a strong presence in North America and Asia. uBriGene focuses on providing comprehensive services that support the development and manufacturing of Advanced Therapy Medicinal Products (ATMPs). The company offers a variety of services, including R&D, clinical, and commercial manufacturing of viral vectors, cell therapies, RNA, and plasmids. uBriGene also conducts quality control testing and supports regulatory filing processes to ensure compliance. Their product offerings include viral vectors, plasmids, cell therapy products, RNA solutions, and iPSC generation products. With GMP manufacturing facilities in China and a new facility in the greater Boston area, uBriGene is well-equipped to meet the needs of clients in the cell and gene therapy sector.
Work at uBriGene Biosciences in HR or recruiting? Claim this page
Headcount trend
uBriGene Biosciences went from 22 employees in Oct 2024 to 27 in Sep 2026. Apr to Sep 2026: 3 people joined, 2 left.
Funding rounds
| Date | Round | Money raised | No. | Investors |
|---|---|---|---|---|
| Sep 2022 | Series C | – | 6 |
Org structure
Headcount by department
Peer reviews
Worked with someone at uBriGene Biosciences?
Anonymous peer reviews on OffTheRecord
Similar companies
uBriGene Biosciences FAQ
How many employees does uBriGene Biosciences have?
uBriGene Biosciences has about 27 employees, unchanged over the 3 months to Sep 2026.
What is uBriGene Biosciences's revenue per employee?
uBriGene Biosciences makes about $370K in revenue per employee, based on $10M annual revenue and 27 employees.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.